SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) has emerged as a rare subtype of thoracic tumor, whose prognosis is unfavorable and for which standard therapeutic regimen is presently unavailable. This evidence concerns the gene SMARCA4 and neoplasm of thorax.